Antihypertensive effects of long term treatment with AE0047, a novel long-lasting calcium antagonist, in hypertensive models of rats and dogs

Folia Pharmacologica Japonica

Volumn 109, Issue 6, 1997, Pages 291-301

  Kido, Hideaki ^a   Nishikawa, Masakuni ^a   Hayashi, Kazutaka ^a   Kubo, Yoshiji ^a   Ebisu, Hajime ^a   Egi, Yasuhiro ^a   Shinyama, Hiroshi ^a   Nakamura, Norifumi ^a  

^a Green Cross Company   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ANTAGONIST; CHOLESTEROL; GLUCOSE; LIPID; TRIACYLGLYCEROL; WATANIDIPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG EFFECT; GLUCOSE METABOLISM; HEART LEFT VENTRICLE HYPERTROPHY; HEART RATE; HYPERTENSION; LIPID METABOLISM; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; REFLEX; REMISSION; RENOVASCULAR HYPERTENSION; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA;

EID: 0030964188     PISSN: 00155691     EISSN: None     Source Type: Journal    
DOI: 10.1254/fpj.109.291     Document Type: Article

References (29)

1. 1992 Joint National Committee: The fifth report of the joint committee on detection, evaluation, and treatment of high blood pressure (JNC V). Arch Intern Med 153, 154-183 (1993)
2. Dahnhöf B, Lindholm LH, Hansson L, Schersten B, Ekbom T and Wester PO: Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-Hypertension). Lancet 338, 1281-1285 (1991)
3. Shulman NB, Ford CE, Hall WD, Blaufox MD, Simon D, Langford HG and Schneider KA: Prognostic value of serum creatinine and effect of treatment of hypertension on renal function: results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 13, Supp 1, I80-I93 (1989)
4. Levy D, Garrison RJ, Savage DD, Kannel WB and Castelli WP: Prognostic implication of echocardiographically determined left ventricular mass in the Framingham study. N Eng J Med 322, 1561-1566 (1991)
5. Psaty BM, Hechbert SR, Koepsell TD, Siscovick DS, Raghunathan TE, Weiss NS, Rosendaal FR, Lemaitre RN, Smith NL, Wahl PW, et al: The risk of myocardial infarction associated with antihypertensive drug therapy. JAMA 274, 620-625 (1995)
6. Furberg CD, Psaty BM and Meyer JV: Nifedipine; Dose-related increase in mortality in patients with coronary heart disease. Circulation 92, 1326-1331 (1995)
7. Cruickshank J, Thorp JM and Zacharias FJ: Benefits and potential harm of lowering high blood pressure. Lancet 1, 581-584 (1987)
8. Pahor M, Guralnik JM, Furberg CD, Carbonin P and Havlik RJ: Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old. Lancet 347, 1061-1065 (1996)
9. Elliott HL: Trough: peak ratio and twenty-four-hour blood pressure control. J Hypertens 12, Supp 5, S29-S33 (1994)
10. Bieniaszewski L, Staessen JA, Byttebier G, De Leeuw P, Van Hedent T and Fagard R: Trough-to-peak versus surface ratio in the assessment of antihypertensive agents. APTH Investigators. Ambulatory Blood Pressure and Treatment of Hypertension. Blood Press 4, 350-357 (1995)
11. Zannad F, Matzinger A and Larche J: Trough / peak ratios of once daily angiotensin converting enzyme inhibitors and calcium antagonists. Am J Hypertens 9, 633-643 (1996)
12. Meredith PA and Elliott HL: FDA guidelines on trough: peak ratios in the evaluation of antihypertensive agents. United States Food and Drug Administration. J Cardiovasc Pharmacol 23, Supp 5, S26-S30 (1994)
13. Ohtaki Y, Uchida T, Ogura Y, Nishikawa M, Watanabe M and Yokoyama K: The antihypertensive effect of the novel Ca entry blocker AE0047 in rat. Eur J Pharmacol 183, 1325-1326 (1990)
14. Zanchetti A, Italian Nifedipine GITS Study Group: Trough: peak ratio of the blood pressure response to dihydropyridine calcium antagonists. J Hypertens 12, Supp 8, S97-S106 (1994)
15. Dunnett CW: New tables for multiple comparisons with a control. Biometrics 20, 482-491 (1964)
16. Perloff D, Sokolow M, Cowan RM and Juster RP: Prognostic value of ambulatory blood pressure measurements: further analysis. J Hypertens 7, Supp 3, S3-S10 (1989)
17. Mancia G, Omboni S, Parati G, Ravogli A, Villani A and Zanchetti A: Lack of placebo effect on ambulatory blood pressure. Am J Hypertens 8, 311-315 (1995)
18. Elliott HL and Meredith PA: Methodological considerations in calculation of the trough: peak ratio. J Hypertens 12, 8 Supp, S3-S7 (1994)
19. Mancia G and Zanchetti A: Trough: peak ratio: measurement, limitations and relevance to treatment of hypertension. Workshop proceedings. 4 February 1994, Vienna, Austria. J Hypertens 12, 8 Supp, S1-S119 (1994)
20. Schmieder RE and Messerli FH: Reversal of left ventricular hypertrophy: a desirable therapeutic goal? J Cardiovasc Pharmacol 16, Supp 6, S16-S22 (1990)
21. Chevalier B, Heudes D, Heymes C, Basset A, Dakhli T, Bansard Y, Jouquey S, Hamon G, Bruneval P, Swynghedauw B, et al: Trandolapril decreases prevalence of ventricular ectopic activity in middle-aged SHR. Circulation 92, 1947-1953 (1995)
22. Marcus ML, Harrison DG, Chilian WM, Koyanagi S, Inou T, Tomanek RJ, Martins JB, Eastham CL and Hiratzka LF: Alterations in the coronary circulation in hypertrophied ventricles. Circulation 75, Supp 1, I19-I25 (1987)
23. Wikstrand J and Kendall M: The role of beta receptor blockade in preventing sudden death. Eur Heart J 13, Supp D, 111-120 (1992)
24. Kannel WB, D'Aostino RB, Levy D and Belanger AJ: Prognostic significance of left ventricular hypertrophy. Circulation 78, 4 Supp II, 89 (1988)
25. Kannel WB: Hypertension, hypertrophy, and the occurrence of cardiovascular disease. Am J Ned Sci 302, 199-204 (1991)
26. Messerli FH, Nunez BD, Nunez MM, Garavaglia GE, Schmider RE and Ventura HO: Hypertension and sudden cardiac death: disparate effects of calcium entry blocker and diuretic therapy. Arch Intern Med 149, 1263-1267 (1989)
27. Lundgren H, Bengtsson C, Lapidus L and Bengtsson L: Antihypertensive drugs and glucose metabolism: comparison between a diuretics, a beta-blocker and felodipine, a new calcium antagonist in subjects with arterial hypertension and diabetes. J Intern Med 228, 597-602 (1990)